{"id":211697,"name":"LUPIN, INC.","slug":"lupin-inc","state":"MD","country":"United States of America","description":"Manufacturer of generic pharmaceuticals, biosimilars, and branded pharmaceuticals.","totalSpending":750000,"filings":16,"yearlySpending":[{"year":2021,"income":100000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":50000}],"issues":["HCR","DEF"],"firms":["MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)"],"lobbyists":["JOHN MILNE","JEFFREY WIENER","ALLEN SHOFE","CRAIG ROBERTS"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office"],"sampleDescriptions":["Advocacy for U.S. production of key pharmaceuticals necessary to support the U.S. supply chain related to pandemic preparedness and prevention","Advocacy for U.S. production of key pharmaceuticals necessary to support the U.S. supply chain related to pandemic preparedness and prevention","Advocacy for U.S. production of key pharmaceuticals necessary to support the U.S. supply chain related to pandemic preparedness and prevention","Advocacy for U.S. production of key pharmaceuticals necessary to support the U.S. supply chain related to pandemic preparedness and prevention","Advocacy for U.S. production of key pharmaceuticals necessary to support the U.S. supply chain related to pandemic preparedness and prevention"],"years":[2021,2022,2023,2024,2025]}